
ASH 2020: Study suggests opportunity to personalise immunotherapy for patients with large B cell lymphoma
CD58 aberrations limit durable responses to CD19 CAR in large B cell lymphoma patients treated…
CD58 aberrations limit durable responses to CD19 CAR in large B cell lymphoma patients treated…